Views
2 years ago

The Discovery of GSK2251052: A First-in-Class Boron ... - Anacor

The Discovery of GSK2251052: A First-in-Class Boron ... - Anacor

The Discovery of GSK2251052: A First-in-Class Boron ... -

The Discovery of GSK2251052: A First-in-Class Boron-Containing Antibacterial Agent Targeting Leucyl tRNA Synthetase Vincent Hernandez Director, Medicinal Chemistry Anacor Pharmaceuticals, Inc. Palo Alto, CA vhernandez@anacor.com

Novel Boron-containing Aminoacyl-tRNA Synthetase ... - Anacor
Discovery of a Novel Class of Boron-Based Antibacterials ... - Anacor
AN3365 (GSK2251052):a Novel Boron Antibiotic for the ... - Anacor
Synthesis and evaluation of novel a-amino cyclic boronates ... - Anacor
Boron and non-boron HCV NS3/4 protease inhibitors: new ... - Anacor
Novel Cyclic Boronates as HCV NS3/4A Protease Inhibitors ... - Anacor
Discovery of Novel Orally Bioavailable Oxaborole 6 ... - Anacor
AN2718 has Broad Spectrum Antifungal Activity Necessary ... - Anacor
In Vitro Activity and In Vivo Efficacy of (S)-3-(aminomethyl ... - Anacor
A New Class of Solar Cells: Isomeric Boron Carbide ...
First Principles Study of Boron in Amorphous Silicon Iván Santos1,2 ...
First Report of Class 1 and Class 2 Integrons in Multidrug-Resistant ...